Multi-Gene Assay Predicts Recurrence In Newly Diagnosed Breast Cancer
FOLFOX 4 Should Be First-Line Therapy For Advanced Disease, NCCTG Finds
Surgery Without Radiation Found Inadequate for DCIS
QOL With Femara Comparable To Placebo, Analysis Finds
EMEND Improved Emesis In Men And Women, Trials Find
Biopsies Could Be Reduced By Computer-Aided-Detection
Chemo+Radiation Preserves Voice, RTOG Study Finds
Low-Dose IFN Not Effective Against Melanoma, Study Finds
NeoPharm To Begin Phase III Trial For Glioblastoma
Elderly Men Say Physicians Are Recommending PSA Tests
NCI-Approved Protocols Listed
Trending Stories
- Richard Pazdur left FDA to avoid being part of “the destruction of the American medical system”
- In first NCAB director’s report, Anthony Letai focuses on centralized grant review, budget outlook
- Pazdur leaves FDA after 25-year career that shaped the agency’s oncology regulations
BIO calls for the end of “constant turmoil,” urges the administration to “right the ship” - Pediatric cancer five-year survival rate has increased dramatically, AACR says in inaugural Pediatric Cancer Progress Report
- Anthony Letai pledges to ensure stability for extramural and intramural cancer science
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program
